Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Renasant Corporation (RNST) A Good Stock To Buy?

How do we determine whether Renasant Corporation (NASDAQ:RNST) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows that their consensus long positions have historically outperformed the market when we adjust for known risk factors.

Is Renasant Corporation (NASDAQ:RNST) a cheap investment today? The smart money is becoming less hopeful. The number of bullish hedge fund positions retreated by 4 in recent months. Our calculations also showed that RNST isn’t among the 30 most popular stocks among hedge funds.

At the moment there are tons of indicators stock traders use to assess publicly traded companies. Some of the best indicators are hedge fund and insider trading signals. We have shown that, historically, those who follow the best picks of the top money managers can trounce their index-focused peers by a solid margin (see the details here).

Roger Ibbotson Zebra Capital

Let’s take a gander at the latest hedge fund action regarding Renasant Corporation (NASDAQ:RNST).

What does the smart money think about Renasant Corporation (NASDAQ:RNST)?

At Q4’s end, a total of 13 of the hedge funds tracked by Insider Monkey were long this stock, a change of -24% from the previous quarter. Below, you can check out the change in hedge fund sentiment towards RNST over the last 14 quarters. So, let’s see which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

RNST_apr2019

The largest stake in Renasant Corporation (NASDAQ:RNST) was held by Renaissance Technologies, which reported holding $17.3 million worth of stock at the end of December. It was followed by Royce & Associates with a $4.3 million position. Other investors bullish on the company included AlphaOne Capital Partners, Algert Coldiron Investors, and Citadel Investment Group.

Because Renasant Corporation (NASDAQ:RNST) has experienced falling interest from the aggregate hedge fund industry, it’s safe to say that there was a specific group of hedgies that decided to sell off their entire stakes in the third quarter. Intriguingly, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital sold off the biggest stake of the 700 funds tracked by Insider Monkey, comprising an estimated $3.1 million in stock, and Noam Gottesman’s GLG Partners was right behind this move, as the fund dumped about $2.1 million worth. These moves are interesting, as aggregate hedge fund interest fell by 4 funds in the third quarter.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as Renasant Corporation (NASDAQ:RNST) but similarly valued. These stocks are Columbia Financial, Inc. (NASDAQ:CLBK), Pacira Pharmaceuticals Inc (NASDAQ:PCRX), Mack Cali Realty Corp (NYSE:CLI), and Opko Health Inc. (NASDAQ:OPK). This group of stocks’ market valuations match RNST’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
CLBK 6 25171 -1
PCRX 25 540796 0
CLI 9 115323 -2
OPK 15 5892 1
Average 13.75 171796 -0.5

View table here if you experience formatting issues.

As you can see these stocks had an average of 13.75 hedge funds with bullish positions and the average amount invested in these stocks was $172 million. That figure was $34 million in RNST’s case. Pacira Pharmaceuticals Inc (NASDAQ:PCRX) is the most popular stock in this table. On the other hand Columbia Financial, Inc. (NASDAQ:CLBK) is the least popular one with only 6 bullish hedge fund positions. Renasant Corporation (NASDAQ:RNST) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. Our calculations showed that top 15 most popular stocks) among hedge funds returned 24.2% through April 22nd and outperformed the S&P 500 ETF (SPY) by more than 7 percentage points. Unfortunately RNST wasn’t nearly as popular as these 15 stock (hedge fund sentiment was quite bearish); RNST investors were disappointed as the stock returned 12.5% and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 15 most popular stocks) among hedge funds as 13 of these stocks already outperformed the market this year.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...